Olympus Co. (OTCMKTS:OCPNY) Sees Significant Increase in Short Interest

Olympus Co. (OTCMKTS:OCPNYGet Rating) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 152,400 shares, an increase of 1,651.7% from the March 31st total of 8,700 shares. Based on an average daily trading volume, of 555,800 shares, the short-interest ratio is currently 0.3 days.

OTCMKTS:OCPNY remained flat at $$18.79 during midday trading on Wednesday. The company had a trading volume of 141,328 shares, compared to its average volume of 400,814. The business’s 50-day simple moving average is $19.10 and its two-hundred day simple moving average is $20.90. Olympus has a 52-week low of $16.80 and a 52-week high of $24.26. The company has a current ratio of 1.97, a quick ratio of 1.47 and a debt-to-equity ratio of 0.71.

Olympus (OTCMKTS:OCPNYGet Rating) last posted its earnings results on Friday, February 4th. The company reported $0.17 EPS for the quarter. The firm had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.86 billion. Equities analysts forecast that Olympus will post 0.72 EPS for the current year.

Separately, Zacks Investment Research lowered Olympus from a “hold” rating to a “sell” rating in a report on Wednesday, April 13th.

About Olympus (Get Rating)

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services.

Read More

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.